Bryn Mawr Trust CO Ani Pharmaceuticals Inc Transaction History
Bryn Mawr Trust CO
- $5.88 Billion
- Q3 2025
A detailed history of Bryn Mawr Trust CO transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Bryn Mawr Trust CO holds 22 shares of ANIP stock, worth $2,022. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22
Previous 28
21.43%
Holding current value
$2,022
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ANIP
# of Institutions
250Shares Held
20.1MCall Options Held
19.9KPut Options Held
12.8K-
Black Rock Inc. New York, NY2.66MShares$244 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$117 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$92.3 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.862KShares$79.3 Million3.45% of portfolio
-
State Street Corp Boston, MA716KShares$65.8 Million0.0% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.6B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...